The presence of glycated forms of Aβ and tau in Alzheimer's disease (AD) and the immunohistochemical localization of AGEs suggests, that protein glycation acts as a common detrimental posttranslational modification of major NDD – associated proteins [7,8]. Here, MAPT is linked to Alzheimer disease.